propranolol has been researched along with Raynaud Disease in 25 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
Excerpt | Relevance | Reference |
---|---|---|
"Five dialysis patients with residual hypertension were treated with a new sustained-release formulation of propranolol (160 mg per capsule) in a dosage of 1 to 2 capsules per day." | 3.66 | Raynaud's phenomenon in hypertensive dialysis patients taking a sustained-release propranolol formulation. ( Gabriel, R; Poulter, N, 1979) |
"Thirty-six patients with Raynaud's disease (RD) were treated with a low dosage of beta-blockers, atenolol (50 mg/day) or propranolol (20 mg/day)." | 1.27 | Beta-blockers: a new therapeutic approach to Raynaud's disease. ( Brotzu, G; Palmina, P; Roberto, M; Susanna, F, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (96.00) | 18.7374 |
1990's | 1 (4.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clement, DL | 1 |
Zahavi, I | 1 |
Chagnac, A | 1 |
Hering, R | 1 |
Davidovich, S | 1 |
Kuritzky, A | 1 |
Meyer, FH | 1 |
Richter, MA | 1 |
Glancy, DL | 1 |
Akman, D | 1 |
Mahajan, R | 1 |
Halperin, JL | 1 |
Cohen, RA | 2 |
Coffman, JD | 3 |
Holti, G | 1 |
Marshall, AJ | 1 |
Roberts, CJ | 2 |
Barritt, DW | 2 |
Marshall, A | 1 |
Thulesius, O | 1 |
Frishman, W | 1 |
Silverman, R | 1 |
Strom, J | 1 |
Elkayam, U | 1 |
Sonnenblick, E | 1 |
Eliasson, K | 1 |
Lins, LE | 1 |
Sundqvist, K | 1 |
Reynolds, DG | 1 |
Turtinen, LW | 1 |
Kerr, JC | 1 |
Swan, KG | 1 |
Steiner, JA | 1 |
Cooper, R | 1 |
Gear, JS | 1 |
Ledingham, JG | 1 |
Wauters, JP | 1 |
Schaller, MD | 1 |
Brunner, HR | 1 |
Poulter, N | 1 |
Gabriel, R | 1 |
Marsden, CW | 1 |
Bayliss, PF | 1 |
Franssen, C | 1 |
Wollersheim, H | 1 |
de Haan, A | 1 |
Thien, T | 1 |
Rasmussen, HM | 1 |
Cleophas, TJ | 1 |
Fennis, JF | 1 |
van 't Laar, A | 1 |
Brotzu, G | 2 |
Susanna, F | 1 |
Roberto, M | 1 |
Palmina, P | 1 |
Bolognini, G | 1 |
Iezzi, GB | 1 |
Ardemagni, G | 1 |
Carboni, MG | 1 |
Falchi, S | 1 |
Montisci, R | 1 |
Petruzzo, P | 1 |
Lepäntalo, M | 1 |
Lindström, BL | 1 |
Tötterman, KJ | 1 |
Sturm, A | 1 |
Axford, AT | 1 |
Gilchrist, L | 1 |
5 trials available for propranolol and Raynaud Disease
Article | Year |
---|---|
A comparison of two beta-blocking drugs in patients with Raynaud's phenomenon.
Topics: Acebutolol; Adult; Body Temperature; Clinical Trials as Topic; Double-Blind Method; Female; Humans; | 1982 |
Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; H | 1979 |
The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Flow Velocity; Blood Pressure; Double-Blind Method; Female | 1992 |
Effects of beta-adrenoreceptor-blocking drugs in patients with Raynaud's phenomenon.
Topics: Adrenergic beta-Antagonists; Adult; Female; Fingers; Hemodynamics; Humans; Metoprolol; Middle Aged; | 1985 |
Alpha and beta-blockade and beta-stimulation in Raynaud's syndrome: a double-blind, placebo controlled, single dose study.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Adult; Double-Blind Method; Female; Fingers; Hemod | 1985 |
20 other studies available for propranolol and Raynaud Disease
Article | Year |
---|---|
Studies on the effect of alpha- and of beta-adrenergic blocking agents on the circulation in human limbs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cold Temperature; Hand; Hemodyna | 1980 |
Prevalence of Raynaud's phenomenon in patients with migraine.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Child; Ergotamine; Female; Humans; Male; Middl | 1984 |
Raynaud's disease in patients with mitral valvular prolapse.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Mitral Valve Prolapse; Propranolol; Raynaud Disease | 1983 |
Digital vasodilatation during mental stress in patients with Raynaud's disease.
Topics: Adult; Atropine; Blood Pressure; Female; Fingers; Heart Rate; Humans; Indomethacin; Male; Middle Age | 1983 |
Vasospasm--ubiquitous?
Topics: Angina Pectoris; Angina Pectoris, Variant; Female; Humans; Male; Migraine Disorders; Muscle, Smooth; | 1981 |
Raynaud's phenomenon as side effect of beta-blockers in hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Female; Humans; Hypertension; Male; Methyldopa; Middle | 1976 |
Letter: Raynaud's phenomenon as side effect of beta-blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Oxprenolol; Propranolol; Raynaud Disease | 1976 |
Beta-adrenergic blockade and vasospasm.
Topics: Adrenergic beta-Antagonists; Humans; Metoprolol; Propranolol; Raynaud Disease; Vasoconstriction | 1979 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bronchi; Central Nervous System Diseases; Deafnes | 1979 |
Vasospastic phenomena in patients treated with beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Circulation; Cardiac Output; Female; Humans; Hyperten | 1979 |
Adrenergic theory: application to clinical and experimental surgery.
Topics: Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Antagonists; Angina Pectoris; Aortic Valve | 1975 |
[Discontinuation of chronic hemodialysis due to improved kidney function caused by the control of arterial hypertension].
Topics: Adult; Creatinine; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Nitroprusside; Propr | 1979 |
Raynaud's phenomenon in hypertensive dialysis patients taking a sustained-release propranolol formulation.
Topics: Delayed-Action Preparations; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Raynaud D | 1979 |
Letter: Raynaud's phenomenon as side effect of beta-blockers.
Topics: Blood Pressure; Humans; Methyldopa; Propranolol; Raynaud Disease | 1976 |
Beta-blockers: a new therapeutic approach to Raynaud's disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Cold Temperature; Humans; Propranolol; Raynaud Disease; Vasoc | 1987 |
[Documentation with Doppler velocimetry of a typical collateral effect of beta-blocking agents].
Topics: Female; Humans; Middle Aged; Propranolol; Raynaud Disease; Rheology; Vascular Resistance | 1986 |
The role of presynaptic beta-receptors in Raynaud's disease.
Topics: Adult; Atenolol; Feedback; Female; Humans; Isoproterenol; Male; Middle Aged; Propranolol; Raynaud Di | 1985 |
Adrenoceptor blocking drugs and cold feet in intermittent claudication.
Topics: Aged; Foot; Humans; Hypertension; Intermittent Claudication; Labetalol; Male; Middle Aged; Propranol | 1986 |
[Letter: Peripheral blood circulation disorders due to beta receptor blockers?].
Topics: Adrenergic beta-Antagonists; Arterial Occlusive Diseases; Humans; Oxprenolol; Propranolol; Raynaud D | 1974 |
Propranolol in the treatment of hypertension.
Topics: Blood Pressure; Cold Temperature; Drive; Humans; Hypertension; Libido; Propranolol; Raynaud Disease; | 1971 |